Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yilu Fang

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
JAMIA Open|March 8, 2024
Retrieval augmented scientific claim verificationHao Liu, Ali Soroush, Jordan G Nestor, et al.
Journal of Biomedical Informatics|May 2, 2024
Criteria2Query 3.0: Leveraging generative large language models for clinical trial eligibility query generationJimyung Park, Yilu Fang, Casey Ta, et al.
Journal of the American Medical Informatics Association : JAMIA|March 6, 2024
Sociotechnical feasibility of natural language processing-driven tools in clinical trial eligibility prescreening for Alzheimer's disease and related dementiasBetina Idnay, Jianfang Liu, Yilu Fang, et al.
Studies in Health Technology and Informatics|May 27, 2021
Participatory Design of a Clinical Trial Eligibility Criteria Simplification MethodYilu Fang, Jae Hyun Kim, Betina Ross Idnay, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|June 23, 2023
Principal Investigators' Perceptions on Factors Associated with Successful Recruitment in Clinical TrialsBetina Idnay, Alex Butler, Yilu Fang, et al.
Journal of Clinical and Translational Science|October 13, 2023
Uncovering key clinical trial features influencing recruitmentBetina Idnay, Yilu Fang, Alex Butler, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Strong protective effect of the <i>APOL1</i> p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney diseaseYask Gupta, David J Friedman, Michelle McNulty, et al.
Nature Communications|November 30, 2023
Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney diseaseYask Gupta, David J Friedman, Michelle T McNulty, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
JAMIA Open|March 8, 2024
Retrieval augmented scientific claim verificationHao Liu, Ali Soroush, Jordan G Nestor, et al.
Journal of Biomedical Informatics|May 2, 2024
Criteria2Query 3.0: Leveraging generative large language models for clinical trial eligibility query generationJimyung Park, Yilu Fang, Casey Ta, et al.
Journal of the American Medical Informatics Association : JAMIA|March 6, 2024
Sociotechnical feasibility of natural language processing-driven tools in clinical trial eligibility prescreening for Alzheimer's disease and related dementiasBetina Idnay, Jianfang Liu, Yilu Fang, et al.
Studies in Health Technology and Informatics|May 27, 2021
Participatory Design of a Clinical Trial Eligibility Criteria Simplification MethodYilu Fang, Jae Hyun Kim, Betina Ross Idnay, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|June 23, 2023
Principal Investigators' Perceptions on Factors Associated with Successful Recruitment in Clinical TrialsBetina Idnay, Alex Butler, Yilu Fang, et al.
Journal of Clinical and Translational Science|October 13, 2023
Uncovering key clinical trial features influencing recruitmentBetina Idnay, Yilu Fang, Alex Butler, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Strong protective effect of the <i>APOL1</i> p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney diseaseYask Gupta, David J Friedman, Michelle McNulty, et al.
Nature Communications|November 30, 2023
Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney diseaseYask Gupta, David J Friedman, Michelle T McNulty, et al.
Pageof 3